Public Book: “100 Questions and Answers About Peripheral Artery Disease” (see: http://www.jblearning.com/catalog/9780763758660/)
1. Hirsch AT, Criqui MH, Treat-Jacobson D, Regensteiner JG, Creager MA, Olin JW, Krook SH, Hunninghake DB, Comerota AJ, Walsh ME, McDermott MM, Hiatt WR. Peripheral arterial disease detection, awareness, and treatment in primary care. J Am Med Assoc 2001;286:1317-1324.
2. Stewart KJ, Hiatt WR, Regensteiner JG, Hirsch AT. Medical progress: exercise training for claudication. New Engl J Med 2002; 347(24):1941-1951.
3. Creager MA, Hirsch AT, Cooke JP, Olin JW, Jaff MR, Rooke T, Halperin JL. On behalf of the Working Group on Fellowship Training in Vascular Medicine. Postgraduate training in vascular medicine: proposed requirements and standards. Vascular Medicine 2003;8:47-52.
4. Hirsch AT, Gloviczki P, Drooz A, Lovell M, and Creager MA on behalf of the Trustees of the Vascular Disease Foundation. The mandate for creation of a national PAD public awareness program: an opportunity to improve cardiovascular health. J Vasc Surg 2004;39:474-481 (co-published in: J Vasc Endovasc Surg; J Vasc Nursing; J Vasc Interventional Radiol; Vascular Medicine ; International Angiology; Angiology; Endovascular Today)
5. Hirsch AT, Haskal ZJ, Hertzer NR, et al. ACC/AHA guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients with Peripheral Arterial Disease [Lower Extremity, renal, Mesenteric, and Abdominal Aortic]). Circulation 2006;113:1474-1547; and J Am Coll Cardiol, 2006;47:1239-1312.
6. Hirsch AT. The treatment of peripheral arterial disease - extending “Intervention” to “Therapeutic Choice”. New England J Med 2006;354(18):1944-1947.
7. Hirsch AT. Critical limb ischemia and stem cell research. Anchoring hope with informed adverse event reporting. Circulation. 2006;114:2581-2583.
8. Hirsch AT, Murphy TP, Lovell MB, Twillman G, Treat-Jacobson D, Harwood E, Mohler ER, Creager MA, Hobson RW, Robertson RM, Howard WJ, Criqui MH. Gaps in public knowledge of peripheral arterial disease: the First National PAD Public Awareness Survey. Circulation 2007;116(18):2086-2094.
9. Murphy TP, Hirsch AT, Ricotta JJ, Cutlip DE, Mohler E, Regensteiner JG, Comerota AJ, Cohen DJ, on behalf of the CLEVER Steering Committee. The National Institutes of Health CLEVER Study (Claudication: Exercise Vs. Endoluminal Revascularization): Rationale and Methods. J Vasc Surg 2008;47(6):1356-1363.PMCID: PMC2519609
10. Hirsch AT, Hartman L, Town RJ, Virnig BA. National healthcare costs of peripheral arterial disease in the Medicare population. Vasc Med 2008;;13(3):209-215.
11. Mahoney EM. Wang K, Keo HH, Duval S, Smolderan K, Cohen D, Steg PG, Bhatt DL, and Hirsch AT, on behalf of the REACH Registry Investigators. Annual vascular hospitalization rates and costs in patients with peripheral arterial disease in the United States. Circulation: Quality and Outcomes 2010, In press.
Hennrikus D, Joseph A, Lando HA, Duval S, Kodl M, Ukestad L, Hirsch AT. Effectiveness of a smoking cessation program for peripheral artery disease patients: A randomized controlled trial. J Amer Coll Cardiol 2010;56;2105-2112.